By Jonathan Gardner | Published August 20, 2026 In a significant development for the rare disease community,...
Treatment Innovations
The pharmaceutical industry is currently witnessing an unprecedented escalation in digital capability. On Monday, Bristol Myers Squibb...
In a significant milestone for colorectal surgery, Colospan—a wholly owned subsidiary of Galmed Pharmaceuticals—has announced the successful...
In the high-stakes world of pharmaceutical development, a quiet revolution has been unfolding—one that predates the current...
In the high-stakes world of pharmaceutical formulation, time is the ultimate currency. Formulation scientists are perpetually caught...
The landscape of modern medicine is undergoing a seismic shift. As generative artificial intelligence (GenAI) evolves from...
Introduction: A Regulatory Agency in Transition The U.S. Food and Drug Administration (FDA), long considered the "gold...
As the United States grapples with its most significant measles resurgence in 35 years, the federal government...
In a significant advancement for perioperative care and neuro-monitoring, Masimo, a subsidiary of the Danaher Corporation, has...
The U.S. Food and Drug Administration (FDA) has officially finalized its long-awaited guidance regarding formal meetings between...
